Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Zoledronic Acid Disodium
2. Zoledronate Disodium Anhydrous
3. 165800-07-7
4. 5csv5k1879
5. 131654-46-1
6. Unii-5csv5k1879
7. Dtxsid80157167
8. Akos015969312
9. J-010228
10. Q27261841
11. Phosphonic Acid, (1-hydroxy-2-(1h-imidazol-1-yl)ethylidene)bis-, Disodium Salt
12. Phosphonic Acid, P,p'-(1-hydroxy-2-(1h-imidazol-1-yl)ethylidene)bis-, Sodium Salt (1:2)
Molecular Weight | 316.05 g/mol |
---|---|
Molecular Formula | C5H8N2Na2O7P2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 315.96021316 g/mol |
Monoisotopic Mass | 315.96021316 g/mol |
Topological Polar Surface Area | 159 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 322 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A zoledronic acid anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of zoledronic acid anhydrous, including repackagers and relabelers. The FDA regulates zoledronic acid anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. zoledronic acid anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A zoledronic acid anhydrous supplier is an individual or a company that provides zoledronic acid anhydrous active pharmaceutical ingredient (API) or zoledronic acid anhydrous finished formulations upon request. The zoledronic acid anhydrous suppliers may include zoledronic acid anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of zoledronic acid anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A zoledronic acid anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of zoledronic acid anhydrous active pharmaceutical ingredient (API) in detail. Different forms of zoledronic acid anhydrous DMFs exist exist since differing nations have different regulations, such as zoledronic acid anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A zoledronic acid anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. zoledronic acid anhydrous USDMF includes data on zoledronic acid anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The zoledronic acid anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of zoledronic acid anhydrous suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing zoledronic acid anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for zoledronic acid anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture zoledronic acid anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain zoledronic acid anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a zoledronic acid anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of zoledronic acid anhydrous suppliers with NDC on PharmaCompass.
zoledronic acid anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of zoledronic acid anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right zoledronic acid anhydrous GMP manufacturer or zoledronic acid anhydrous GMP API supplier for your needs.
A zoledronic acid anhydrous CoA (Certificate of Analysis) is a formal document that attests to zoledronic acid anhydrous's compliance with zoledronic acid anhydrous specifications and serves as a tool for batch-level quality control.
zoledronic acid anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each zoledronic acid anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
zoledronic acid anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (zoledronic acid anhydrous EP), zoledronic acid anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (zoledronic acid anhydrous USP).
LOOKING FOR A SUPPLIER?